Fenglei Zhang
Inventor
Stats
- 9 US patents issued
- 59 US Applications filed
- most recent filing
This is official USPTO record data
Details
- 9 US Patents Issued
- 59 US Applications Filed
- 279 Total Citation Count
- Apr 17, 2024 Most Recent Filing
- Apr 23, 2004 Earliest Filing
Work History
| Patent Owner | Applications Filed | Year |
|---|---|---|
| INCYTE HOLDINGS CORPORATION | 2
2 2 2 3 1 4 | 2004
2008 2011 2013 2014 2015 2016 |
| INCYTE CORPORATION | 1
1 5 5 3 | 2008
2014 2015 2016 2017 |
Inventor Addresses
| Address | Duration |
|---|---|
| Ambler, PA, US | Jul 03, 14 - Nov 28, 24 |
| Berwyn, PA, US | Jun 07, 18 - Nov 07, 24 |
| Lansdale, PA | Dec 23, 04 - Dec 23, 04 |
| Lansdale, PA, US | May 14, 09 - Jan 28, 14 |
Technology Profile
| Technology | Matters | |
|---|---|---|
| A61K: | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | 28 |
| A61P: | THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS | 19 |
| C07C: | ACYCLIC OR CARBOCYCLIC COMPOUNDS | 1 |
Patents / Publication
| Patents / Publication # | Year of Publication / Issued | Title | Citations |
|---|---|---|---|
| 2024/0390,340 | 2024 | PYRROLIDINE KRAS INHIBITORS | 0 |
| 2024/0368,152 | 2024 | QUINOLINE COMPOUNDS AS INHIBITORS OF KRAS | 0 |
| 11873309 | 2024 | Heterocyclic compounds as immunomodulators | 0 |
| 2023/0357,255 | 2023 | IMIDAZOPYRIMIDINES AND TRIAZOLOPYRIMIDINES AS A2A / A2B INHIBITORS | 0 |
| 2023/0226,062 | 2023 | HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS | 7 |
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level.
>
Upgrade to our Level for up to -1 portfolios!.